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IgA Nephropathy S37complete remission (CR) rates of proteinuria in the combination group and
MP group were 57.35% and 57.28% at the first 12 months of follow-up within
171 patients. Time to CR in the MP group and combination group was 16
(2e44) weeks and 12 (2e36) weeks (P Z 0.237). Time to partial remission
(PR) in the combination group was shorter than in the MP group, 8 (4e36)
weeks versus 12 (4e48) weeks, respectively (PZ 0.037). Kaplan Meier curve
showed the renal survival rate in combination group was significantly higher
than the MP group (ORZ 5.688, PZ 0.017). However, the primary endpoint
was similar in the two groups, 3 patients in the MP group and 2 in the com-
bination group (P Z 0.968).
Conclusion: MMF combined with glucocorticoids could reduce proteinuria as
effectively as glucocorticoids and get shorter time to PR in IgAN patients
with proteinuria  1 g/day. Combined MMF and glucocorticoids treatment
led to a better renal survival compared to glucocorticoids alone in the
long-term follow up.http://dx.doi.org/10.1016/j.hkjn.2015.08.105
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Clinicopathological Characteristics of Primary IgA Nephropathy with
Crescentic Formation in Adults
Xiaoxia Yu
Department of Nephrology, Central Hospital of Dalian City, Dalian City,
China
Objective: To understand the clinic-pathological features of the primary IgA
nephropathy (IgAN) with crescentic formation in adults.
Methods: Clinicopathological data of 32 adults with primary Cr IgAN (obser-
vation group) and 56 adults with primary IgAN (control group) were
compared.
Results: Crescent formation has a high incidence (32.6%) in primary IgA
nephropathy. Clinically, most of the patients (86%) showed rapidly pro-
gressive glomerulonephritis. Gross hematuria was noted in 70%, protein-
uria and renal dysfunction significantly increased in observation group
(P < 0.05). Pathologically, cases with fibrinoid necrosis, capillary endo-
thelial proliferation and tubulointerstitial damage were more than the
control group (P < 0.01).
Conclusion: The clinical manifestation and renal lesions of IgAN with cres-
centic in adults are worse than those without, thus we should take positive
clinical treatment to improve the prognosis of this disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.106
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Objective: To analyze the influence of hyperuricemia on renal tubulointer-
stitium in IgA nephropathy patients with normal renal function and provide a
basis for the selection of clinical treatment.
Methods: Retrospective analysis of 86 patients hospitalized in Nephrology
Department in the First Affiliated Hospital of Liaoning Medical University from
July 2011 to July 2014was conducted. The patients’ renal biopsy results showed
primary IgAnephropathyandtheir renal functionwasnormal. Theyweredivided
into normal uric acid group and hyperuricemia group on the basis of uric acid
level, and clinical data reflecting tubulointerstitial injury, renal pathological
data and changes in clinical lab index after treatment of decreasing uric acid
were collected. Statistical method was applied to analyze the results.
Results: Among 86 patients, the normal uric acid group was of 52 cases, 34
cases with hyperuricemia. Clinical observations and pathological features
reflecting tubulointerstitial injury: Compared with normal uric acid group, hy-
peruricemia group had increased urinary b2-microglobulin, urinary retinol
binding protein and urinary N-acetyl-b-D aminoglycosidase and decreased
urine osmotic pressure (P < 0.05), and increased Oxford tubulointerstitial
score and Katafuchi semi quantitative score of renal tubulointerstitium
(P < 0.05). Of the 34 cases, 28 cases received treatment of decreasing uric
acid using allopurinol for 4 weeks and were reviewed regularly. After thetreatment, the patients’ uric acid level significantly decreased, urine osmotic
pressure increased, urinary b2-microglobulin, urinary retinol binding protein
and urinary N-acetyl-b-D-amino-glucosaminidase decreased (P < 0.05).
Table 1. Relationship between blood uric acid level and clinical lab index
ðx  SÞ.
Clinical lab index Normal uric acid Hyperuricemiagroup groupUrine osmotic pressure
(mOsm/kg)817.5  144.5 551.6  63.3Urinary b2-MG (mg/L) 127.5  46.2 414.2  97.6
Urinary RBP (mg/L) 0.18  0.04 0.24  0.05
Urinary NAGL (mg/L) 25.4  6.2 42.6  7.8P ＜ 0.05.
Table 2. Changes in clinical lab index before and after treatment.
Clinical lab index Before treatment After treatmentUrine osmotic pressure (mOsm/kg) 521.6  45.7 668.5  56.8
Urinary b2-MG (mg/L) 423.2  87.5 326.7  84.6
Urinary RBP (mg/L) 0.27  0.06 0.18  0.08
Urinary NAGL (mg/L) 39.7  7.6 28.6  6.9P ＜ 0.05.
Conclusion: IgA nephropathy patients with normal renal function patients
with hyperuricemia had more severe tubular interstitial lesion. They should
be given early intervention on hyperuricemia, which plays an important role
in reducing risk factors and slowing the progression of the disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.107
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Objective: To investigate the relationships between the serum 25-hydroxy
vitamin D3 levels with clinical and pathological features in patients with pri-
mary IgA nephropathy (IgAN), analyse the influence factos of abnormal
levels of 25-hydroxy vitamin D3.
Methods: The clinical and pathological datas of 166 cases wth primary IgA ne-
phropathy were retrospectively analyzed. The study investigated the serum
25-hydroxy vitamin D3 levels and maked a correlation analysis of 25-hydroxy
vitamin D3 levels and IgAN. The prevalence of 25-hydroxy vitamin D3 defi-
ciency or insufficiency was calculated and influence factors with abnormal
25-hydroxy vitamin D3 level were analyzed in the patients with IgAN.
Results: A total of 166 patients with IgAN had complete data and the mean
age was 32.32 13.09 years, of which 82 were males and 84 were females.
The average value of 25-hydroxy vitamin D3 was 43.71 19.93 nmol/L. We
found 93.39% of patients with IgAN in the study had 25-hydroxy vitamin D3
deficiency or insufficiency. The prevalence of normal, deficiency and insuf-
ficiency of 25-hydroxy vitamin D3 were 3.62%, 48.19% and 48.20%, respec-
tively. Blood albumin, eGFR, haemoglobin, IgG, C3 were positively
associated and blood urea nitrogen, uric acid, T-chol, TG, LDL, HDL, ESR,
24-hour urinary protein content, systolic pressure, mesangial cell prolifera-
tion, renal tubule atrophy and interstitial fibrosis were negatively associated
with 25-hydroxy vitamin D3 level (P < 0.05). Serum albumin, eGFR and pro-
teinuria are independent risk factors of abnormal level of 25-hydroxy
vitamin D3 in the patients with IgAN (P < 0.05).
Conclusion:There is significant higher incidenceof 25-hydroxy vitamin D3 defi-
ciency or insufficiency in those patientswith IgAN. The25-hydroxy vitaminD3 is
closely associated with anemia, proteinuria, hyperlipidemia, hypertension
mesangial cell proliferation, renal tubule atrophy and interstitial fibrosis in pa-
tients with IgAN. Serum albumin, eGFR and urine protein are risk factors of
abnormal levels of 25-hydroxy vitamin D3 in those patients with IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.108
